Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus

Journal of Human Hypertension volume 16, pages 539–547 (2002)Cite this article

Abstract

We compared the levels of microparticles, platelet activation markers, soluble cell adhesion molecules, and soluble selectins between hypertensive patients with and without type 2 diabetes and control subjects. Binding of anti-glycoprotein IIb/IIIa and anti-glycoprotein Ib monoclonal antibodies to platelets did not differ significantly between the hypertensive patients and controls, but platelet expression of activation markers (CD62P, CD63, PAC-1, and annexin V) was higher in the hypertensive patients. Platelet-derived microparticle (PDMP) and monocyte-derived microparticle (MDMP) levels were significantly higher in the hypertensive patients than in the controls. Soluble ICAM-1, VCAM-1, P-selectin, and E-selectin levels were also higher in the hypertensive patients, and they were significantly higher in the hypertensive patients with diabetes. After treatment with efonidipine, the levels of PDMPs, CD62P-, CD63-, PAC-1-, and annexin V-positive platelets, sICAM-1, sVCAM-1, sP-selectin, and sE-selectin all decreased significantly. The MDMP levels decreased, and the decrease was significant in the hypertensive patients with diabetes. These findings suggest that administration of efonidipine to hypertension patients with diabetes may prevent the development of cardiovascular complications caused by cell adhesion molecules or activated platelets and monocytes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Davis TM, Cull CA, Holman RR . Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: UK Prospective Diabetes Study (UKPDS 55) Diabetes Care 2001; 24: 1167–1174

    Article  CAS  PubMed  Google Scholar 

  2. Opie LH . Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivity Cardiovasc Drugs Ther 1993; 6: 19–24

    Article  Google Scholar 

  3. Lichtlen PR et al. Retardation of angiographic progression of coronary artery disease by nifedipine Lancet 1990; 335: 1109–1113

    Article  CAS  PubMed  Google Scholar 

  4. Waters D et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis Circulation 1990; 82: 1940–1953

    Article  CAS  PubMed  Google Scholar 

  5. Johnson H . Effects of nifedipine (Adalat) on platelet function in vitro and in vivo Thromb Res 1981; 21: 523–528

    Article  Google Scholar 

  6. McDonagh RF, Rauzzino MJ . Stimulated leukocyte adhesion in coronary microcirculation is reduced by a calcium antagonist Am J Physiol 1993; 34: H476–H483

    Google Scholar 

  7. Alexander JJ, Miguel R, Piotrowski JJ . The effect of nifedipine on lipid and monocyte infiltration of the subendothelial space J Vasc Surg 1993; 17: 841–847

    Article  CAS  PubMed  Google Scholar 

  8. Viele D, Betz E . Effect of the calcium entry blocker. Flunarizine, on ruthenium red uptake by endothelial cells following acute electrical stimulation of rabbit carotid arteries Basic Res Cardiol 1985; 80: 58–65

    Article  Google Scholar 

  9. Tedgui A, Chiron B, Curmi P, Juan L . Effect of nicardipine and verapamil on in vitro albumin transport in rabbit thoracic aorta Atherosclerosis 1987; 7: 80–87

    CAS  Google Scholar 

  10. McMurray HF, Chahwala SB . Amoldipine exerts a potent antimigrational effect on aortic smooth muscle cells in culture J Cardiovasc Pharmacol 1992; 20 (Suppl): S54–S56

    Google Scholar 

  11. Yang Z, Noll G, Luscher TF . Calcium antagonists differently inhibit proliperation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor Circulation 1993; 88: 832–836

    Article  CAS  PubMed  Google Scholar 

  12. Cominacini L et al. Elevated levels of soluble E-selectin inpatients with IDDM and NIDDM: relation to metabolic control Diabetologia 1995; 38: 1122–1124

    Article  CAS  PubMed  Google Scholar 

  13. Fries JWU et al. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation Am J Pathol 1993; 143: 725–737

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Davies MJ et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM-1, and E-selectin in human atherosclerosis J Pathol 1993; 171: 223–229

    Article  CAS  PubMed  Google Scholar 

  15. Ross R . The pathogenesis of atherosclerosis: a prospective study for the 1990s Nature 1993; 362: 801–809

    Article  CAS  PubMed  Google Scholar 

  16. Beekhuizen H, van Furth R . Monocyte adherence to human vascular endothelium J Leukoc Biol 1993; 54: 363–378

    Article  CAS  PubMed  Google Scholar 

  17. Jonasson L, Holm J, Bondjers G, Hansson GK . Regional accumlation of T cells, macrophages, and smoothmuscle cells in the human athero-sclerotic plaque Arteriosclerosis 1986; 6: 131–138

    Article  CAS  PubMed  Google Scholar 

  18. Drake TA et al. Minimally oxidized LDL induces tissue factor expression in cultured human endothelial cells Am J Pathol 1991; 138: 601–607

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Osnes LTN, Westvik AB, Kieruf P . Procoagulant and profibrinolytic activities of cryopreserved human monocytes Thromb Res 1994; 76: 373–383

    Article  CAS  PubMed  Google Scholar 

  20. Mesri M, Altieri DC . Endothelial cell activation by leukocyte microparticles J Immunol 1998; 161: 4382–4387

    CAS  PubMed  Google Scholar 

  21. Robinson RA, Worfolk L, Tracy PB . Endotoxin enhances the expression of monocyte prothrombinase activity Blood 1992; 79: 406–416

    CAS  PubMed  Google Scholar 

  22. Murakami T et al. Flow cytometric analysis of platelet activation markers CD62P and CD63 inpatients with coronary artery disease Eur J Clin Invest 1996; 26: 996–1003

    Article  CAS  PubMed  Google Scholar 

  23. Miyazaki Y et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles Blood 1996; 88: 3456–3464

    CAS  PubMed  Google Scholar 

  24. Masumiya H, Shijuku T, Tanaka H, Shigenobu K . Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect Eur J Pharmacol 1998; 349: 351–357

    Article  CAS  PubMed  Google Scholar 

  25. Saito T et al. Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics inpatients with stable effort angina Arzneimittelforschung 1996; 46: 861–867

    CAS  PubMed  Google Scholar 

  26. Yokoyama T, Ichikawa K, Abiko Y . Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: comparison with nifedipine Fundam Clin Pharmacol 1997; 11: 245–251

    Article  CAS  PubMed  Google Scholar 

  27. Takeda M, Shou I, Tomino Y . Effects of the antihypertensive drug efonidipine hydrochroride on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes Gen Pharmacol 1998; 30: 749–752

    Article  CAS  PubMed  Google Scholar 

  28. The National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group Report on Hypertension in diabetes Hypertension 1994; 23: 145–158

  29. The Expert Commitee on the Diagnosisa and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes meelitus Diabetes Care 1997; 20: 1183–1197

  30. Nomura S et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus Atherosclerosis 1995; 116: 235–240

    Article  CAS  PubMed  Google Scholar 

  31. Nomura S et al. Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation Cytometry 2000; 40: 173–181

    Article  CAS  PubMed  Google Scholar 

  32. Miyake T et al. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation Thromb Haemost 1997; 78: 902–909

    Article  CAS  PubMed  Google Scholar 

  33. Nomura S et al. Effects of EDTA on membrane glycoprotein IIb-IIIa complex: analysis using flow cytometry Thromb Res 1987; 47: 47–58

    Article  CAS  PubMed  Google Scholar 

  34. Yanabu M et al. Tyrosine phosphorylation and p72syk activation by an anti-glycoprotein lb monoclonal antibody Blood 1997; 89: 1590–1598

    CAS  PubMed  Google Scholar 

  35. Xie GL, Nomura S, Fukuhara S . Annexin V expression and membrane vesiculation during activation of leukemic cell lines Haemostasis 1987; 27: 259–268

    Google Scholar 

  36. Packham MA, Mustard JF . The role of platelets in the development and complications of atherosclerosis Semin Hematol 1986; 23: 8–19

    CAS  PubMed  Google Scholar 

  37. Levy PJ et al. Inhibition of platelet aggregability by losartan in essential hypertension Am J Cardiol 2000; 86: 1188–1192

    Article  CAS  PubMed  Google Scholar 

  38. Tomoda F et al. Different platelet aggregability during mental stress in two stages of essential hypertension Am J Hypertens 1999; 12: 1063–1070

    Article  CAS  PubMed  Google Scholar 

  39. Gomi T, Ikeda T, Shibuya Y, Nagao R . Effects of antihypertensive treatment on platelet function in essential hypertension Hypertens Res 2000; 23: 567–572

    Article  CAS  PubMed  Google Scholar 

  40. Portaluppi F et al. Platelet alpha 2-adrenoceptor alterations inpatients with essential hypertension are normalized after treatment with doxazosin but not propranolol J Hypertens 2000; 18: 217–221

    Article  CAS  PubMed  Google Scholar 

  41. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ . Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity J Biol Chem 1988; 263: 18205–18212

    CAS  PubMed  Google Scholar 

  42. Nomura S et al. Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease Thromb Haemost 1994; 72: 519–522

    Article  CAS  PubMed  Google Scholar 

  43. Tschope D et al. Flow cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actins status of activated platelets Cytometry 1990; 11: 652–656

    Article  Google Scholar 

  44. Singhal PC et al. Pressure modulates monocyte migration Am J Hypertens 1997; 10: 1297–1301

    Article  CAS  PubMed  Google Scholar 

  45. Dorffel Y et al. Preactivated peripheral blood monocytes inpatients with essential hypertension Hypertension 1999; 34: 113–117

    Article  CAS  PubMed  Google Scholar 

  46. Asagami T, Reaven GM, Tsao PS . Enhanced monocyte adherence to thoracic aortae from rats with two forms of experimental hypertension Am J Hypertens 1999; 12: 890–893

    Article  CAS  PubMed  Google Scholar 

  47. Weyrich AS et al. Activated platelets signal chemokine synthesis by human monocytes J Clin Invest 1996; 97: 1525–1534

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Neumann F-J et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets Circulation 1997; 95: 2387–2394

    Article  CAS  PubMed  Google Scholar 

  49. Verhaar MC et al. Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids Cardiovasc Res 1999; 42: 752–760

    Article  CAS  PubMed  Google Scholar 

  50. Venturini CM, Kaplan JE . Thrombin induces platelet adhesion to endothelial cells Semin Thromb Hemost 1992; 18: 275–283

    Article  CAS  PubMed  Google Scholar 

  51. Springer TA . Adhesion receptors of the immune system Nature 1990; 346: 425–434

    Article  CAS  PubMed  Google Scholar 

  52. Buemi M et al. Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-selectin in normotensive and hypertensivepatients Hypertension 1997; 30: 845–847

    Article  CAS  PubMed  Google Scholar 

  53. Tsao PS et al. Interaction of diabetes and hypertension on determinants of endothelial adhesiveness Arterioscler Thromb Vasc Biol 1998; 18: 947–953

    Article  CAS  PubMed  Google Scholar 

  54. Taddei S et al. Endothelial dysfunction in hypertension J Nephrol 2000; 13: 205–210

    CAS  PubMed  Google Scholar 

  55. Artigues C et al. Increased endothelium-monocyte interactions in salt-sensitive hypertension: effect of L-arginine J Cardiovasc Pharmacol 2000; 35: 468–473

    Article  CAS  PubMed  Google Scholar 

  56. Libby P . Atheroma: more than mush Lancet 1996; 348: S4–S7

    Article  CAS  PubMed  Google Scholar 

  57. Farkas K, Sarman B, Jermendy G, Somogyi A . Endothelial nitric oxide in diabetes mellitus: too much or not enough? Diabetes Nutr Metab 2000; 13: 287–297

    CAS  PubMed  Google Scholar 

  58. Bagg W et al. The influences of obesity and glycemic control on endothelial activation inpatients with type 2 diabetes J Clin Endocrinol Metab 2001; 86: 5491–5497

    Article  CAS  PubMed  Google Scholar 

  59. Riondino S et al. Platelet hyperactivity in hypertensive olderpatients is controlled by lowering blood pressure J Am Geriatr Soc 1999; 47: 943–947

    Article  CAS  PubMed  Google Scholar 

  60. Kaplar M et al. The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy Platelets 2001; 12: 419–422

    Article  CAS  PubMed  Google Scholar 

  61. Watanabe S et al. Calcium antagonist inhibits glomerular cell apotosis and injuries of L-NAME exacerbated nephrosclerosis in SHR Hypertens Res 2000; 23: 683–691

    Article  CAS  PubMed  Google Scholar 

  62. Berkels R et al. Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms Hypertension 2001; 37: 240–245

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was partly supported by a grant from the Japan Foundation of Neuropsychiatry and Hematology Research, A Research Grant for Advanced Medical Care from the Ministry of Health and Welfare of Japan, and a Grant (13670760 to SN) from the Ministry of Education, Science and Culture of Japan.

Author information

Authors and Affiliations

  1. First Department of Internal Medicine, Kansai Medical University, Osaka, Japan

    S Nomura, S Kanazawa & S Fukuhara

Authors
  1. S Nomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Kanazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Fukuhara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Nomura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nomura, S., Kanazawa, S. & Fukuhara, S. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. J Hum Hypertens 16, 539–547 (2002). https://doi.org/10.1038/sj.jhh.1001447

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001447

Keywords

This article is cited by

Search

Advanced search

Quick links